Transcatheter aortic valve implantation in end-stage renal disease

P. Hamilton; A. Coverdale; C. Edwards; J. Ormiston; J. Stewart; M. Webster; J. De Zoysa

doi:10.1093/ckj/sfs039

Transcatheter aortic valve implantation in end-stage renal disease

P. Hamilton, A. Coverdale, C. Edwards, J. Ormiston, J. Stewart, M. Webster, J. De Zoysa

Research output: Contribution to journal › Article › peer-review

Abstract

Valvular heart disease is common in patients with end-stage renal disease and, if symptomatic, may lead to valve replacement surgery. However, some patients with renal failure are deemed unsuitable for cardiac surgery, and in those patients who do undergo surgery, there is a significantly greater morbidity and mortality. Transcatheter aortic valve implantation (TAVI) is recognized as an option for high-risk patients with symptomatic aortic stenosis (AS). Here we describe two patients on haemodialysis who underwent TAVI with satisfactory outcomes. The role of TAVI is evolving and has the potential to play an important role for dialysis patients with AS.

Original language	English
Pages (from-to)	247-249
Number of pages	3
Journal	CKJ: Clinical Kidney Journal
Volume	5
Issue number	3
DOIs	https://doi.org/10.1093/ckj/sfs039
Publication status	Published - 2012

Keywords

Aortic stenosis
End stage renal disease
Haemodialysis
Transcatheter aortic valve implantation
Aortic valve implantation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ckj/sfs039

Cite this

@article{152b2d153b6c49fab68acc68133eaa94,

title = "Transcatheter aortic valve implantation in end-stage renal disease",

abstract = "Valvular heart disease is common in patients with end-stage renal disease and, if symptomatic, may lead to valve replacement surgery. However, some patients with renal failure are deemed unsuitable for cardiac surgery, and in those patients who do undergo surgery, there is a significantly greater morbidity and mortality. Transcatheter aortic valve implantation (TAVI) is recognized as an option for high-risk patients with symptomatic aortic stenosis (AS). Here we describe two patients on haemodialysis who underwent TAVI with satisfactory outcomes. The role of TAVI is evolving and has the potential to play an important role for dialysis patients with AS.",

keywords = "Aortic stenosis, End stage renal disease, Haemodialysis, Transcatheter aortic valve implantation, Aortic valve implantation",

author = "P. Hamilton and A. Coverdale and C. Edwards and J. Ormiston and J. Stewart and M. Webster and {De Zoysa}, J.",

year = "2012",

doi = "10.1093/ckj/sfs039",

language = "English",

volume = "5",

pages = "247--249",

journal = "CKJ: Clinical Kidney Journal",

issn = "2048-8505",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Transcatheter aortic valve implantation in end-stage renal disease

AU - Hamilton, P.

AU - Coverdale, A.

AU - Edwards, C.

AU - Ormiston, J.

AU - Stewart, J.

AU - Webster, M.

AU - De Zoysa, J.

PY - 2012

Y1 - 2012

N2 - Valvular heart disease is common in patients with end-stage renal disease and, if symptomatic, may lead to valve replacement surgery. However, some patients with renal failure are deemed unsuitable for cardiac surgery, and in those patients who do undergo surgery, there is a significantly greater morbidity and mortality. Transcatheter aortic valve implantation (TAVI) is recognized as an option for high-risk patients with symptomatic aortic stenosis (AS). Here we describe two patients on haemodialysis who underwent TAVI with satisfactory outcomes. The role of TAVI is evolving and has the potential to play an important role for dialysis patients with AS.

AB - Valvular heart disease is common in patients with end-stage renal disease and, if symptomatic, may lead to valve replacement surgery. However, some patients with renal failure are deemed unsuitable for cardiac surgery, and in those patients who do undergo surgery, there is a significantly greater morbidity and mortality. Transcatheter aortic valve implantation (TAVI) is recognized as an option for high-risk patients with symptomatic aortic stenosis (AS). Here we describe two patients on haemodialysis who underwent TAVI with satisfactory outcomes. The role of TAVI is evolving and has the potential to play an important role for dialysis patients with AS.

KW - Aortic stenosis

KW - End stage renal disease

KW - Haemodialysis

KW - Transcatheter aortic valve implantation

KW - Aortic valve implantation

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-84861860602&partnerID=MN8TOARS

U2 - 10.1093/ckj/sfs039

DO - 10.1093/ckj/sfs039

M3 - Article

SN - 2048-8505

VL - 5

SP - 247

EP - 249

JO - CKJ: Clinical Kidney Journal

JF - CKJ: Clinical Kidney Journal

IS - 3

ER -

Transcatheter aortic valve implantation in end-stage renal disease

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this